Presenter: Natalie Gustafson, PharmD

Original Date: March 18, 2018

Traditional naltrexone has been used to help patients struggling with addiction to opiates or alcohol. However, for decades we have recognized that at lower dosages, aptly named Low Dose Naltrexone (LDN), we see an entirely different effect on the body. LDN has been shown to have a significant impact on immune function and inflammation. It has been studied and used clinically in Multiple Sclerosis (MS), Crohn’s, Sjogren’s, Hashimoto’s, Lupus, Rheumatoid Arthritis and more. Understanding its mechanisms of action and analyzing literature as well as clinical practice can help practitioners ascertain which patients might benefit from LDN as part of their treatment protocol. There will be a short discussion of adjunctive compounded therapies used in these various conditions, such as biotin and methylcobalamin in MS, topicals for Sjogren’s and thyroid for Hashimoto’s.

1.0 Pharmacology CEUs approved by OBNM